838 followers
Phase II trial of hypoFx VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results https://t.co/jF42z21iL0
Phase II trial of hypoFx VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results https://t.co/jF42z21iL0
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year… https://t.co/5rPT0QUiRn #breastcancer
Radiat Oncol: "Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxic… https://t.co/LNUd9q2o6H